APVO·03835L702·US·equity·Healthcare - Biotechnology-13D/G
APVO (APTEVO THERAPEUTICS INC) is held by 4 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($56,948), UBS Group AG ($14,710), OSAIC HOLDINGS, INC. ($1,535). Net institutional sentiment: Mixed.
See how APVO's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer